Media | Vizimpro

This site is intended only for healthcare professionals in Hong Kong SAR.

Our medicines

Besponsa

Cibinqo

Cresemba

Eliquis

Enbrel

Ibrance

Lorviqua

Ngenla

Nurtec

Paxlovid

Prevenar20

Pristiq

Talzenna

Vizimpro

Vyndamax

Xeljanz

Zavicefta

See All products

Pfizer Hong Kong Price List

Therapy areas

Multiple Myeloma

Non-Small-Cell Lung Cancer

Respiratory Syncytial Virus

Transthyretin Amyloidosis

Search

Menu

Close

Sign In

Log Out

Explore content

Events

Downloadable materials

Videos

Let’s connect

Contact us

Pfizer medical information

Menu

Close

About

Mechanism of action

Guidelines

Efficacy

Study design

Progression-free survival

Response rates

Overall survival

Overall survival: subgroup analysis

Safety

Dosing

Dosing and administration

Recommended dose modifications

Proactive management of adverse events

Efficacy maintained after dose reduction

Support & Resources

Events

Materials

Videos

INDICATION

VIZIMPRO is indicated for the first-line treatment of patients with metastatic nonsmall cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R substitution mutations.¹

Reference:

VIZIMPRO® Prescribing Information. Pfizer Corporation Hong Kong Limited: Version February 2021.

Patient safety is of paramount importance throughout the life cycle of a medicine - and pharmaceutical companies have ethical and regulatory responsibilities to monitor the safety of the products they sell for as long as they are used by consumers anywhere in the world. The Drug Safety Unit at Pfizer Corporation Hong Kong Limited. address product experience reports including adverse events. If you have any experience pertinent to the above, please contact us at (852) 2811 9711 as soon as possible.

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign in

Register

Account

Sign Out

This site is intended only for healthcare professionals resident in to Hong Kong. If you are a member of the public wishing to access information on a specific medicine, please visit www.pfizer.com.hk

The information provided in this site is intended only for Health Professionals who reside in Hong Kong, and the products discussed herein may have different product labeling in different countries/regions. The site is for information purpose only, and nothing herein shall be construed as providing any kind of medical advice or recommendation or product promotion. Pfizer Corporation Hong Kong Limited is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.